We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iofina Plc | LSE:IOF | London | Ordinary Share | GB00B2QL5C79 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.45 | 2.31% | 19.95 | 19.50 | 21.00 | 20.25 | 19.475 | 19.50 | 192,149 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 42.2M | 7.87M | 0.0410 | 4.94 | 38.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/1/2024 08:18 | I thought they say said that IO9 is now where it should be Owenga and has been since mid Q4? Exiting with 750 tonnes capacity seems ok to me. | bocker01 | |
15/1/2024 08:17 | Did we? I didn't. | owenga | |
15/1/2024 08:16 | Owenga- we knew they hadn’t started building IO#10. | chillpill | |
15/1/2024 08:15 | If it’s like last year we might get a financials update in 2-3 weeks time. I think CC figures might be on the light side again. | chillpill | |
15/1/2024 08:13 | Ok update, but too many negatives. Still doesn't seem like io9 is doing very well based on production numbers. Looks like io10 pushed back a quarter to production. Why haven't they already started building it. Iodine products mixed. Iodine price dipped slightly.Only real positive was non iodine production related to semi conductor chips has had a good second half. | owenga | |
15/1/2024 07:55 | Also happy to have what feels to me like more insights into chemicals (albeit high level) And no doubt some will be unhappy not being told the year end cash position, which to me, is a little useless without knowing other working capital items | naphar | |
15/1/2024 07:53 | Happy enough with that especially as IO10 groundwork’s are starting this week, hadn’t expected that given we were still awaiting more detailed timelines following the October announcement. Although original go live timing was mid year so timelines may have slipped a bit givin in October they told us mid year, maybe not though as July could be both, I reckon they are just saying Q3 to protect themselves from delay risk….. if they deliver startup in July then result! | naphar | |
15/1/2024 07:45 | Canaccord say they should finish the year with an annual production rate of 750t. By the time they get IO#11 and 12 built they should be close to 1000t pa. CC don’t seem to have picked up on the Cosayach mine problem. | chillpill | |
15/1/2024 07:42 | All looks steady as she goes to me. The biggest thing is iodine prices are stable so it is all about ramping up production. If they can get IO#11 signed and built by March/April next year they will probably only be one plant away from that 1000t pa. Also putting more products through IC should mean greater profitability. | chillpill | |
15/1/2024 07:33 | Prospects are looking good for the future with production likely to be higher for 2024 and, with IO#10, operating 2025 should see a further increase. | this_is_me | |
13/1/2024 12:31 | 55.0% potential upside indicated by Canaccord Genuity Canaccord Genuity set a target price of 40 GBX for the company, which when compared to the Iofina plc share price of 26 GBX at opening today (12/01/2024) indicates a potential upside of 55.0%. Trading has ranged between 22 (52 week low) and 38 (52 week high) with an average of 182,184 shares exchanging hands daily. The market capitalisation at the time of writing is £47,836,625. Iofina plc is a United Kingdom-based holding company. The Company is a specialist in the exploration and production of iodine and a manufacturer of specialty chemical products. The Company’s principal business is to identify, develop, build, own, and operate iodine extraction plants, focused on North America, based on the Company’s Wellhead Extraction Technology (WET) IOsorb technology. The Company, through its subsidiary, Iofina Resources, Inc., develops, builds, owns, and operates iodine extraction plants using its WET IOsorb technology. The Company, through its subsidiary, Iofina Chemical, Inc., manufactures halogen specialty chemicals derived from raw iodine, as well as non-iodine-based products. Its subsidiary, IofinaEX, Inc., is engaged in the extraction of cannabinoid-based products from hemp. The Company’s production operations are located in the United States, specifically in Kentucky and Oklahoma. Its other subsidiary is Iofina Resources, LLC. | activmojo | |
12/1/2024 09:23 | Looks like next week for an update. | beercapafn | |
09/1/2024 17:57 | Three end day trades of 13 shares just hope that's not a bad omen... | beeezzz | |
08/1/2024 18:03 | Zendo102, Thanks. i am sorry to say that this chemistry is far beyond my comprehension. | varies | |
08/1/2024 13:24 | varies - you need to search the article for halides (which includes fluoride, chloride, bromide and iodide) - I'm not sure if the full report mentions iodine specifically, and I'm not willing to pay the huge price tag to find out! Iodide compounds seem to be promising for this kind of solar cell, though the chemistry of iodides may be behind their instability - see here: This is all speculative technology at the moment. It would be great if researchers solve the issues, but personally, it doesn't affect my investment thesis for IOF. | zendo102 | |
08/1/2024 12:33 | chillpill Thank you for the link. I cannot see any reference to iodine Please point me to it | varies | |
07/1/2024 09:14 | Recent we've been getting a regular visitor from Japan on this forum. Checkout the visitors in the heading. Already been on today 🇯🇵 | activmojo | |
07/1/2024 08:44 | Not sure about this….but will put it out there….. Was looking at a Japanese website and they expect a significant uptake in demand for iodine from next year for Perovskite Solar Cells. | chillpill | |
05/1/2024 15:23 | Activmojo - Again look back at previous market updates. They are often combined with updates on plants. If there is news on IO#10 due, it will probably be combined with the market update. It saves on costs. | zendo102 | |
05/1/2024 14:26 | Thanks Zendo: I am much better informed for your post. | beercapafn | |
05/1/2024 13:35 | Beer, Don't take any notice of the pomposity. An update on IO10 is overdue. | activmojo | |
05/1/2024 09:54 | beercapafn - Why on earth are you disappointed? The year end is the 31st of December and the 1st was a public holiday. So you expect the management team to collect and verify the data, write and check the report and send it to the NOMAD for further checking/approval before getting it to the relevant authorities for publication today? (While at the same time having to deal with time zones…) Let’s look at previous years’ updates for further evidence: 2023 - 9 Jan 2022 - 17 Jan 2021 - 19 Jan 2020 - 16 Jan 2019 - 17 Jan 2018 - 15 Jan 2017 - 13 Jan 2016 - 18 Jan 2015 - 13 Jan So the 2023 update seems to be an outlier for being published as early as the the 9th. So again, expecting an announcement on the 5th just doesn’t make sense. Care to have another guess when the announcement might be? (For example you could check which days of the week update announcements are made to see if there is a pattern.) If you aren’t prepared to do this modicum of research, then it might be best to keep your thoughts to yourself. | zendo102 | |
05/1/2024 07:25 | Disappointed that there was no RNS this morning. Nice share price rises these last few weeks. A positive RNS should see 30p plus. Thanks, Chilllpill - always informative. | beercapafn | |
05/1/2024 07:10 | Had time last night to look into the CC figures. I think EBITDA of $11.5m for last year should be very achievable especially if they achieve projected sales of 350t in H2. Worth noting in 2024 non-iodine revenue expected to jump over 25% from 2023 to $12.5m. | chillpill | |
04/1/2024 22:37 | 283k trades is many buys? | naphar |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions